QSP Model Acceleration via Virtual Population Simulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Quantitative systems pharmacology (QSP) models face challenges due to high computational complexity, instability in capturing multiple timescale phenomena, and an imbalance between model complexity and available data, leading to resource-intensive computations and uncertainty in parameter estimation.
Innovation Solution
The development of a system and method using a multiple-data fitting interface that generates virtual populations based on received data objects, allowing for the creation of virtual clinical trials and expanding data analysis to difficult experimental dimensions through a user-determined or default cost function and global sensitivity analysis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If QSP models integrate datasets from diverse contexts into a mathematical framework to predict outcomes in untested scenarios, then the model's predictive capability and biological insight are improved, but the computational complexity and resource requirements increase significantly
Solution Approach 1:
The QSP model is divided into multiple submodels representing different biological processes (pharmacokinetics, pharmacodynamics, disease progression). Each submodel can be developed, validated, and computed independently, then integrated through a mathematical framework. This segmentation reduces the computational burden of the overall system while maintaining predictive accuracy.
Solution Approach 2:
Extensive preprocessing of diverse datasets is performed before model integration, including data cleaning, normalization, and feature extraction. The mathematical framework is pre-configured with appropriate parameter ranges and constraints. This preliminary preparation reduces computational complexity during the actual prediction phase by avoiding redundant processing.
2Adaptability or versatility
If QSP models capture multiple timescale phenomena (e.g., circadian rhythm spanning hours and transcription factor dynamics in microseconds), then the model's biological realism is improved, but numerical instability and stiffness issues arise
Solution Approach 1:
The mathematical framework dynamically adjusts the timescale of computation for different biological processes. Fast processes (transcription factor dynamics) are computed with smaller time steps, while slow processes (circadian rhythm) use larger time steps. This dynamic timescale adaptation allows the model to capture multiple timescale phenomena accurately without suffering from numerical stiffness.
Solution Approach 2:
The model transforms parameters to handle timescale separation. By introducing dimensionless parameters and rescaling time variables, the stiffness of the differential equations is reduced. This parameter transformation maintains the biological realism of multiple timescale phenomena while improving numerical stability for computation.
3Productivity
If model parameters are learned from limited clinical trial data to generate inferences, then the model's ability to work with available data is improved, but uncertainty in parameter estimation increases
Solution Approach 1:
The mathematical framework introduces intermediate parameters and latent variables that bridge the gap between limited clinical trial data and the complex biological processes. These intermediaries act as mediators that can be constrained by available data while still allowing the model to infer unobserved biological mechanisms, thereby reducing uncertainty in parameter estimation.
Solution Approach 2:
The model incorporates feedback mechanisms where predictions from the QSP model are compared against available clinical trial data, and parameter estimates are iteratively refined. This feedback loop allows the model to maximize information extraction from limited data while quantifying and reducing uncertainty through repeated validation and adjustment.
4Reliability
If comprehensive QSP simulations are performed to analyze global sensitivity and iterate through model development, then the model's robustness and validation are improved, but the compute time required increases
Solution Approach 1:
The comprehensive simulation and analysis process is segmented into modular components: parameter sensitivity analysis, scenario testing, and validation checks. Each module can be executed independently and in parallel, reducing total compute time while maintaining model robustness through systematic evaluation of all critical aspects.
Solution Approach 2:
The mathematical framework implements adaptive sampling strategies for sensitivity analysis, performing comprehensive simulations only for critical parameters and scenarios. For less sensitive parameters, reduced simulations or surrogate models are used. This partial action approach maintains model robustness for key decisions while significantly reducing overall compute time.
Data Source
AI summary
Systems and methods for design optimization using a multiple-data fitting interface are disclosed. Data objects that include pairs of data with information in the form of one or more computational models that model the behavior of multiple items are received. The received data objects are paired into a collection that includes dependencies between the data objects. A virtual population is generated based on the received data objects. The virtual population comprises multiple virtual patients, with each virtual patient comprising a combination of model parameters that describe data in the received data objects. A prediction for the virtual population is generated by simulating with each of the virtual patients. The generation of the virtual population includes a user-determined or default cost function and an algorithm for finding an optimal configuration for the virtual population with respect to said cost. An output is generated that includes a visualization of the prediction.